2018/04/17 MVC Gets Listed on OTC Market on April 17th

Medigen Vaccine Biologics Corp. (MVC, TPEx: 6547) gets listed on OTC market on April 17th. Chairman Dr. Stanley Chang and President Charles Chen lead the rest of the executive team to attend the listing ceremony in Taipei Exchange.

From left to right: MVC Finance Assistant Vice President, Jade Yang; MVC executive director, Bill Ou; MVC President, Professor Charles Chen; MVC Chairman, Dr. Stanley Chang; TPEx President, Su Yuqing; Sinotrade Chairman, Stanley Chu; PwC Accountant, Jackie Feng; TPEx Vice President, Lin Ying-Kuei.

BACK TO LIST
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree